Frankenius Equity AB has filed 4 insider transactions across 1 company since December 2024.
Most recent transaction: a transaction of 759000 shares of TriSalus Life Sciences, Inc. ($TLSI) on July 31, 2025.
Activity breakdown: 1 open-market purchase and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| July 31, 2025 | TriSalus Life Sciences, Inc. | $TLSI | Frankenius Equity AB | TenPercentOwner | C | Common Stock | 759000 | $0.00 | 6,989,748.0000 | 32,272,462 | 12.18% | 2.35% |
| July 31, 2025 | TriSalus Life Sciences, Inc. | $TLSI | Frankenius Equity AB | TenPercentOwner | C | Series A Convertible Preferred Stock | 230000 | $0.00 | 0.0000 | 32,272,462 | 100.00% | 0.71% |
| Feb. 10, 2025 | TriSalus Life Sciences, Inc. | $TLSI | Frankenius Equity AB | Not found | J | Series A Convertible Preferred Stock | 205853 | $0.00 | 435,853.0000 | 0 | 89.50% | 0.00% |
| Dec. 17, 2024 | TriSalus Life Sciences, Inc. | $TLSI | Frankenius Equity AB | Not found | P | Common Stock | 62972 | $3.97 | 6,230,748.0000 | 0 | 1.02% | 0.00% |